title: Efficacy of ondansetron in the treatment of generalized anxiety disorder.
authors.forename: A M
authors.initials: AM
authors.lastname: Freeman
authors.forename: J R
authors.initials: JR
authors.lastname: Westphal
authors.forename: G T
authors.initials: GT
authors.lastname: Norris
authors.forename: B A
authors.initials: BA
authors.lastname: Roggero
authors.forename: P B
authors.initials: PB
authors.lastname: Webb
authors.forename: K L
authors.initials: KL
authors.lastname: Freeman
authors.forename: J A
authors.initials: JA
authors.lastname: Rush
authors.forename: E M
authors.initials: EM
authors.lastname: Hearne
authors.forename: G
authors.initials: G
authors.lastname: Evoniuk
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017294:Ondansetron / Q000009:adverse effects / Q000627:therapeutic use*; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014151:Anti-Anxiety Agents; D012702:Serotonin Antagonists; D017294:Ondansetron; D003975:Diazepam